It is possible that with increasing use of WES or whole genome sequencing (WGS), more patients with KMT2D/KDM6A pathogenic mutations with HPE and/or TA and other conotruncal abnormalities will be identified. The gene discussed is KMT2D; the disease is holoprosencephaly.